gymnema sylvestre glp-1 study In silico exploration of phytochemicals for receptor agonists for the treatment of type 2 diabetes Gymnema sylvestre extract ameliorated streptozotocin‐induced

As the first GLP-1 medication specifically approved for weight loss, it offers substantial outcomes, with clinical trials demonstrating an average body weight reduction of 14.9%

Diabetes Obes Metab (2009) 11:60310

Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model

While effective for weight loss, nausea ranks among the most frequently reported side effects during the first weeks of treatment

But it seems like GLP-1s can help with that too according to clinical trials Disclaimer: This article is written with the help of generative tools so beware of hallucinations

A thorough clinical assessment is necessary to identify the underlying cause and determine appropriate management